Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
53 hedge funds and large institutions have $40.5M invested in Marrone Bio Innovations, Inc. in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
8% more funds holding
Funds holding: 49 → 53 (+4)
17% less capital invested
Capital invested by funds: $49M → $40.5M (-$8.49M)
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$927K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$244K |
| 3 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$131K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$135K |
| 2 |
Primecap Management
Pasadena,
California
|
-$74.2K |
| 3 |
Morgan Stanley
New York
|
-$72.3K |
| 4 |
Goldman Sachs
New York
|
-$53.5K |
| 5 |
BlackRock
New York
|
-$50.5K |
MBII Hedge Fund Activity: Q1 2020 in Review
53 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2020, worth a combined $40.5M — down 17% from $49M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBII positions and 4 closed out — a net gain of 6 holders — while 13 added to existing stakes and 17 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $927K. The largest seller was Essex Investment Management, cutting an estimated $135K.
- 53 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2020, up from 49 in Q4 2019.
- Funds reported $40.5M of Marrone Bio Innovations, Inc. stock for Q1 2020, down 17% quarter-over-quarter.
- 10 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2020 and 4 closed out, a net change of +6 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2020 was Ardsley Advisory Partners, an estimated $927K added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2020 was Essex Investment Management, an estimated $135K sold.
Based on aggregated 13F filings for Q1 2020.